[Thrombotic microangiopathy associated with cancer is an oncologic emergency: a case report].
Blot
E
E
Marie
I
I
Delastre
O
O
Cailleux
N
N
Pouillart
P
P
Lévesque
H
H
Courtois
H
H
D000230:Adenocarcinoma / Q000150:complications* / Q000188:drug therapy; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage; D004211:Disseminated Intravascular Coagulation / Q000150:complications; D005472:Fluorouracil / Q000008:administration & dosage; D006461:Hemolysis; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D013927:Thrombosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D014747:Vinblastine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077235:Vinorelbine
D000925:Anticoagulants; D000972:Antineoplastic Agents, Phytogenic; D014747:Vinblastine; D006493:Heparin; D002945:Cisplatin; D000077235:Vinorelbine; D005472:Fluorouracil
La microangiopathie thrombotique associée au cancer est une urgence carcinologique: à propos d'un cas.